CBD and Drug Interactions: What You Need to Know Before Starting
Affiliate Disclosure: This post may contain affiliate links. We may earn a commission if you purchase through our links at...
Read morePerimenopause spans 4-10 years of hormonal fluctuation causing hot flashes, night sweats, mood swings, brain fog, joint pain, and insomnia. CBD addresses multiple symptoms simultaneously: anti-inflammatory effects reduce joint pain, anxiolytic properties calm mood instability, and sleep-promoting effects improve rest quality. By supporting the endocannabinoid system (which regulates temperature, mood, and sleep), CBD offers comprehensive symptom management without hormone replacement.
Start with 15-20mg daily and increase to 25-40mg based on symptom response. Many perimenopausal women benefit from split dosing: morning dose for daytime mood and joint symptoms, evening dose (15-20mg) for sleep and night sweats. Full-spectrum formulas retain terpenes with hormone-supportive properties. Consistency matters more than dose—daily use produces better results than sporadic dosing.
For temperature regulation, consider CBD with adaptogenic herbs like rhodiola or ashwagandha, which support hormonal balance. Evening softgels or tinctures help normalize sleep-wake cycles and reduce nocturnal sweating. Topical CBD oils rubbed on the chest and neck may offer localized cooling sensation during hot flashes. Some women report combination therapy works best: oral CBD daily plus topical relief during acute flashes.
Perimenopausal mood swings and brain fog respond well to CBD. The compound supports serotonin regulation and reduces inflammation linked to cognitive decline. Many women report improved mood stability within 2-3 weeks at 20-30mg daily. For brain fog, consider CBD combined with other nootropic supports: omega-3s, B vitamins, and adequate sleep (which CBD improves). Journaling mood and focus helps track CBD’s cognitive benefits.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more